These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 26258910)
1. An evolution in switching therapy for psoriasis patients who fail to meet treatment goals. Kerdel F; Zaiac M Dermatol Ther; 2015; 28(6):390-403. PubMed ID: 26258910 [TBL] [Abstract][Full Text] [Related]
2. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options. Neri L; Miracapillo A G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808 [TBL] [Abstract][Full Text] [Related]
3. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission. Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816 [TBL] [Abstract][Full Text] [Related]
4. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment. Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093 [TBL] [Abstract][Full Text] [Related]
5. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation. Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130 [TBL] [Abstract][Full Text] [Related]
6. Current and Under Development Treatment Modalities of Psoriasis: A Review. Albaghdadi A Endocr Metab Immune Disord Drug Targets; 2017; 17(3):189-199. PubMed ID: 28782467 [TBL] [Abstract][Full Text] [Related]
7. Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. Imafuku S; Zheng M; Tada Y; Zhang X; Theng C; Thevarajah S; Zhao Y; Song HJ J Dermatol; 2018 Jul; 45(7):805-811. PubMed ID: 29740870 [TBL] [Abstract][Full Text] [Related]
8. Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group. Ganzetti G; Campanati A; Bettacchi A; Brandozzi G; Brisigotti V; Bugatti L; Cataldi I; Filosa G; Giacchetti A; Lemme G; Morresi L; Nicolini M; Postacchini V; Ricotti G; Rosa L; Simonacci M; Offidani A G Ital Dermatol Venereol; 2018 Feb; 153(1):5-10. PubMed ID: 27845513 [TBL] [Abstract][Full Text] [Related]
9. Concept of Remission in Chronic Plaque Psoriasis. Gisondi P; Di Mercurio M; Idolazzi L; Girolomoni G J Rheumatol Suppl; 2015 Nov; 93():57-60. PubMed ID: 26523059 [TBL] [Abstract][Full Text] [Related]
10. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420 [TBL] [Abstract][Full Text] [Related]
11. The role of biologics in the treatment of moderate-to-severe plaque psoriasis. Puig L G Ital Dermatol Venereol; 2017 Feb; 152(1):28-35. PubMed ID: 27627100 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of psoriasis: before and now]. Osmancevic A; Ståhle M Lakartidningen; 2017 Nov; 114():. PubMed ID: 29292946 [TBL] [Abstract][Full Text] [Related]
13. Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE. Zweegers J; van den Reek JM; van de Kerkhof PC; Otero ME; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Kievit W; de Jong EM Br J Dermatol; 2014 Nov; 171(5):1091-8. PubMed ID: 24861358 [TBL] [Abstract][Full Text] [Related]
14. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity. Vaidya TS; Anderson KL; Feldman SR Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437293 [TBL] [Abstract][Full Text] [Related]
15. Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments. Kamel JG; Yamauchi PS Drugs Aging; 2017 Aug; 34(8):583-588. PubMed ID: 28755089 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream. Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160 [TBL] [Abstract][Full Text] [Related]
17. Treatment of severe psoriasis. Puig L J Eur Acad Dermatol Venereol; 2012 Aug; 26 Suppl 5():17-8. PubMed ID: 22758913 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302 [TBL] [Abstract][Full Text] [Related]
19. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics. Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143 [TBL] [Abstract][Full Text] [Related]
20. Use of biologic agents in combination with other therapies for the treatment of psoriasis. Cather JC; Crowley JJ Am J Clin Dermatol; 2014 Dec; 15(6):467-78. PubMed ID: 25373522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]